Patent details

Basic Information

Publication number:

EP3134092

PCT Application Number:

US2015026060

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157826082

PCT Publication Number:

WO2015164160

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST

French Title of Invention:

SELS PHARMACEUTIQUES D'UN ANTAGONISTE DES RÉCEPTEURS DE L'OREXINE

German Title of Invention:

PHARMAZEUTISCHE SALZE EINES OREXINREZEPTORANTAGONISTEN

SPC Number:

Dates

Filing date:

16/04/2015

Grant date:

24/06/2020

EP Publication Date:

01/03/2017

PCT Publication Date:

29/10/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/06/2020

EP B1 Publication Date:

24/06/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/04/2021

Expiration date:

16/04/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/06/2020

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

MCNEVIN, Michael

Address:

United States (US)

2

Name:

LOHANI, Sachin

Address:

United States (US)

Priority

Priority Number:

201461981889 P

Priority Date:

21/04/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/423; A61K 31/551; C07D 413/14;

Publication

European Patent Bulletin

Issue number:

202026

Publication date:

24/06/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages